ArticleTransportation research. Part E, Logistics and transportation review2022
The supply chain of blood products in the wake of the COVID-19 pandemic: Appointment scheduling and other restrictions.
Article in Transportation research. Part E, Logistics and transportation review, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Lessons learned from crises in blood donation services: A systematic review of operational practices.Vox sanguinis · 2026Pooled it
- Optimizing patient flow logistics: strategic challenges, tactical solutions, and future directions.BMC health services research · 2025Pooled it
- Multi-objective two-stage emergent blood transshipment-allocation in COVID-19 epidemic.Complex & intelligent systems · 2023Article
- Distributionally robust optimization of a Canadian healthcare supply chain to enhance resilience during the COVID-19 pandemic.Computers & industrial engineering · 2022Article
- A mathematical model for managing the multi-dimensional impacts of the COVID-19 pandemic in supply chain of a high-demand item.Annals of operations research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work, we formulate the blood products supply chain problem in the wake of disasters such as the COVID-19 (SARS-CoV-2) pandemic using two-stage stochastic programming where uncertainty of both demand and supply is considered. The products considered are red blood cells (RBCs), plasma, and platelets. Age-based demand and blood type substitution are included in our model. A heuristic is developed to solve the instances a commercial optimization software failed to solve in a reasonable amount of time. To obtain managerial insight a sensitivity analysis is conducted. Results of the analysis show that bigger capacities of permanent collection facilities are favored over the mobility of temporary facilities while accounting for blood substitution and age-based demand in the planning phase reduced shortages significantly. Moreover, different objective functions were considered to ensure fairness in distribution of the products among hospitals. The fairer distribution resulted in an increase in the total unmet demand.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.